company background image
DHR logo

Danaher NYSE:DHR Stock Report

Last Price

US$251.65

Market Cap

US$186.1b

7D

1.6%

1Y

1.7%

Updated

27 Feb, 2024

Data

Company Financials +

DHR Stock Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.

DHR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for DHR from our risk checks.

Narratives

Beta

Narratives bring a range of perspectives from our community.

Danaher Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Danaher
Historical stock prices
Current Share PriceUS$251.65
52 Week HighUS$269.61
52 Week LowUS$182.09
Beta0.87
1 Month Change8.00%
3 Month Change13.09%
1 Year Change1.66%
3 Year Change12.30%
5 Year Change100.76%
Change since IPO28,279.94%

Recent News & Updates

Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Feb 10
Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Recent updates

Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Feb 10
Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term

Jan 30

Is Danaher (NYSE:DHR) Using Too Much Debt?

Jan 12
Is Danaher (NYSE:DHR) Using Too Much Debt?

My Top 2024 Stock Pick: Danaher

Dec 27

Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles

Nov 26

RGA Investment Advisors - Danaher:  Purity In The Crown Jewel Of Bioprocessing

Nov 19

Why Danaher Is One Of My Favorite Long-Term Investments

Oct 26

Danaher: Short-Term Headwinds, But Long-Term Tailwinds

Oct 17

Should Danaher Investors Sell New Veralto Shares?

Oct 02

Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Sep 30
Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Danaher: A Lost Year

Aug 30

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

Aug 02

Danaher: A Compounding Icon At A Fair Price

Jul 25

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Jul 13
These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Jun 28
Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump

Jun 22

At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Jun 15
At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Danaher: A Great Chance To Buy This Long-Term Compounder

May 23

With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Apr 26
With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Estimating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Mar 28
Estimating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?

Mar 15
Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?

Is Danaher (NYSE:DHR) Using Too Much Debt?

Mar 02
Is Danaher (NYSE:DHR) Using Too Much Debt?

Danaher ups dividend by 8% to $0.27

Feb 22

Danaher Q4 2022 Earnings Preview

Jan 23

Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?

Jan 16
Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?

We Have A Winner! Revisiting Danaher And Thermo Fisher

Jan 11

Danaher downgraded to neutral at Credit Suisse on exposure to inventory reductions

Jan 05

A Look At The Fair Value Of Danaher Corporation (NYSE:DHR)

Dec 18
A Look At The Fair Value Of Danaher Corporation (NYSE:DHR)

Danaher: A Great Business - The Price Where I Would Buy

Dec 14

Danaher declares $0.25 dividend

Dec 06

When Should You Buy Danaher Corporation (NYSE:DHR)?

Dec 04
When Should You Buy Danaher Corporation (NYSE:DHR)?

Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?

Nov 20
Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?

Danaher Q3 2022 Earnings Preview

Oct 19

Is Now The Time To Put Danaher (NYSE:DHR) On Your Watchlist?

Oct 12
Is Now The Time To Put Danaher (NYSE:DHR) On Your Watchlist?

Danaher's Cash Flow Profile Is Stellar

Sep 21

Shareholder Returns

DHRUS Life SciencesUS Market
7D1.6%2.4%1.8%
1Y1.7%2.7%25.1%

Return vs Industry: DHR underperformed the US Life Sciences industry which returned 2.8% over the past year.

Return vs Market: DHR underperformed the US Market which returned 25.6% over the past year.

Price Volatility

Is DHR's price volatile compared to industry and market?
DHR volatility
DHR Average Weekly Movement3.0%
Life Sciences Industry Average Movement7.4%
Market Average Movement6.1%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.1%

Stable Share Price: DHR has not had significant price volatility in the past 3 months.

Volatility Over Time: DHR's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196962,000Rainer Blairhttps://www.danaher.com

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands.

Danaher Corporation Fundamentals Summary

How do Danaher's earnings and revenue compare to its market cap?
DHR fundamental statistics
Market capUS$186.15b
Earnings (TTM)US$4.20b
Revenue (TTM)US$23.89b

44.3x

P/E Ratio

7.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DHR income statement (TTM)
RevenueUS$23.89b
Cost of RevenueUS$9.76b
Gross ProfitUS$14.13b
Other ExpensesUS$9.93b
EarningsUS$4.20b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)5.68
Gross Margin59.14%
Net Profit Margin17.58%
Debt/Equity Ratio34.4%

How did DHR perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

18%

Payout Ratio

Does DHR pay a reliable dividends?

See DHR dividend history and benchmarks
When do you need to buy DHR by to receive an upcoming dividend?
Danaher dividend dates
Ex Dividend DateMar 27 2024
Dividend Pay DateApr 26 2024
Days until Ex dividend29 days
Days until Dividend pay date59 days

Does DHR pay a reliable dividends?

See DHR dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.